There were no significant variations in absolute values of calcemia during the study between subgroups of patients treated with haloperidol, clozapine, olanzapine, risperidone or two antipsychotic drugs. However, in patients treated with olanzapine the mean magnitude of all calcemia changes from the baseline was significantly greater (-5.8±6.8%, n=27) than in serum samples of subjects treated with another antipsychotic (-1.7±5.0%, n=100) (Mann-Whitney test, p=0.002). Moreover, in serum samples of patients who took olanzapine there was three times greater odd to detect a drop than an increase of calcemia from baseline (22/5 vs. 56/44; p=0.028; OR=3.46, 1.21-9.86). The opposite was in the patients taking haloperidol in whom a significant trend of increasing calcemia from baseline was detected in all serum samples (26/27 vs. 52/22; p=0.025; OR=0.41, 0.20-0.85). Interestingly, in serum samples from eleven patients taking two antipsychotics the mean magnitude of all calcemia changes from the baseline was negative but significantly smaller (-0.4±3.2%, n=38) than in subjects treated with antipsychotic monotherapy (-3.5±6.3%, n=89) (Mann-Whitney test, p=0.004). Subject taking combined treatment almost exclusively used haloperidol (10 subjects) as well as chlorpromazine, fluphenazine and sulpiride (one subject each).
